Integrated medical records can reduce disparities between blacks and whites in HIV care

June 26, 2017

FINDINGS

A streamlined and integrated method of tracking medical records called a laboratory health information exchange narrowed the gap in anti-retroviral therapy and viral suppression between HIV-positive blacks and whites, according to UCLA researchers. Also, the use of these exchanges led to Latinos who are HIV-positive being more likely than whites of using anti-retroviral therapy and improving viral suppression.

At the beginning, blacks in the study used antiretroviral therapy about 25 percent less often than whites did, but, their rates were equivalent by the end. Similarly blacks began the study with 25 percent lower rates of viral suppression than whites, but their rates were equivalent by the end.

Although Latinos' anti-retroviral therapy use and viral suppression was equivalent to that of whites at the start of the study, after the intervention their levels were 77 percent and 33 percent greater, respectively.

Overall, viral suppression for blacks and Latinos increased by 16 percent compared to the period prior to implementation of the exchange.

BACKGROUND


To better maintain continuity of care for people with HIV, health care providers have increasingly adopted health information exchanges that maintain clinical information, laboratory test results and anti-retroviral therapy prescription filling that augment electronic medical records. Previous UCLA-led research by the same authors about laboratory health information exchange systems found that when the system detected clinically important increases in a person's viral load, the health care provider changed the anti-retroviral therapy an average of 6 days earlier than before the information exchange was implemented.

Blacks and Latinos are disproportionately affected by HIV, the virus that causes AIDS, and less likely than whites to receive the ongoing, sustained care that is crucial to maintaining their health and viral suppression. For this new study, the researchers examined whether a laboratory health information exchange would increase rates of anti-retroviral therapy use and viral suppression for a large clinic population and if it would reduce racial/ethnic disparities in these outcomes.

METHOD


The researchers examined monthly anti-retroviral therapy use and prescription fills and approximately, quarterly HIV lab results culled between December 2007 and November 2011 from electronic medical records for 1,181 people with HIV at a Southern California HIV/AIDS clinic. They examined rates of anti-retroviral therapy use and viral suppression one year before and two years after start of the laboratory health information exchange.

IMPACT


Use of laboratory health information exchanges in HIV care can both improve use of anti-retroviral therapy and viral suppression for all people living with HIV and reduce disparities between blacks and whites in HIV health care and outcomes.
-end-
AUTHORS

The authors of this study are Dr. William Cunningham, Chandra Ford, Janni Kinsler, Danielle Seiden, Terry Nakazono and Dr. Douglas Bell, all of UCLA, and Laral Andrews, of Eisner Health.

JOURNAL


The study was published in the peer-reviewed Journal of Acquired Immune Deficiency Syndromes.

FUNDING


This study was funded by grants from the Health Resources and Services Administration; the National Institutes of Health/National Institute on Aging; NIH/National Institute on Minority Health and Health Disparities; National Center for Advancing Translational Sciences; NIH/National Institute on Drug Abuse; NIH/National Institute of Nursing Research; and the UCLA California Center for Population Research through support from the Shriver National Institute of Child Health and Human Development.

University of California - Los Angeles Health Sciences

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.